Cary Fu

1.5k total citations
34 papers, 937 citations indexed

About

Cary Fu is a scholar working on Genetics, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Cary Fu has authored 34 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 15 papers in Cognitive Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Cary Fu's work include Genetics and Neurodevelopmental Disorders (17 papers), Autism Spectrum Disorder Research (13 papers) and Tuberous Sclerosis Complex Research (6 papers). Cary Fu is often cited by papers focused on Genetics and Neurodevelopmental Disorders (17 papers), Autism Spectrum Disorder Research (13 papers) and Tuberous Sclerosis Complex Research (6 papers). Cary Fu collaborates with scholars based in United States, Denmark and Australia. Cary Fu's co-authors include Robert J. Maier, Kevin C. Ess, Robert P. Carson, Jack W. Olson, Peggy Winzenburger, Farhad Moshiri, Jeffrey L. Neul, Eric D. Marsh, Alan K. Percy and Adrienne N. Bruce and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Cary Fu

30 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cary Fu United States 17 418 367 227 115 106 34 937
Hong Chang China 18 279 0.7× 400 1.1× 88 0.4× 23 0.2× 106 1.0× 62 833
Zhengyu Cao China 15 231 0.6× 324 0.9× 108 0.5× 10 0.1× 30 0.3× 30 667
Xiaolu Deng China 12 167 0.4× 252 0.7× 149 0.7× 12 0.1× 87 0.8× 35 689
Paul Yao China 19 165 0.4× 284 0.8× 225 1.0× 21 0.2× 87 0.8× 44 992
Xukun Liu China 15 143 0.3× 235 0.6× 207 0.9× 20 0.2× 72 0.7× 25 646
Wenchao Li China 14 76 0.2× 144 0.4× 73 0.3× 7 0.1× 88 0.8× 48 646
Tanja Matijević Glavan Croatia 15 69 0.2× 224 0.6× 31 0.1× 29 0.3× 29 0.3× 35 613
Kejin Zhang China 15 106 0.3× 210 0.6× 83 0.4× 47 0.4× 41 0.4× 63 671
Liping Hou China 15 218 0.5× 230 0.6× 53 0.2× 27 0.2× 96 0.9× 52 686
Xiaofeng Zhao China 18 107 0.3× 363 1.0× 81 0.4× 42 0.4× 46 0.4× 60 869

Countries citing papers authored by Cary Fu

Since Specialization
Citations

This map shows the geographic impact of Cary Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cary Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cary Fu more than expected).

Fields of papers citing papers by Cary Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cary Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cary Fu. The network helps show where Cary Fu may publish in the future.

Co-authorship network of co-authors of Cary Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Cary Fu. A scholar is included among the top collaborators of Cary Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cary Fu. Cary Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campbell, Kathleen, Jeffrey L. Neul, David N. Lieberman, et al.. (2025). A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome. Journal of Neurodevelopmental Disorders. 17(1). 4–4.
2.
Percy, Alan K., Robin Ryther, Eric D. Marsh, et al.. (2025). Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2–4 years with Rett syndrome. Med. 6(6). 100608–100608.
3.
Fu, Cary, Jeffrey L. Neul, Tim A. Benke, et al.. (2024). MECP2 Variants in Males: More Common than Previously Appreciated. Pediatric Neurology. 161. 263–267. 3 indexed citations
4.
May, Dave A., Charles Ruetsch, Xin Yang, Simon D. Kyle, & Cary Fu. (2023). EPH83 Characteristics, Comorbid Gi Conditions, and Treatment Patterns Among Individuals Diagnosed with Rett Syndrome. Value in Health. 26(6). S179–S179.
5.
Neul, Jeffrey L., Tim A. Benke, Eric D. Marsh, et al.. (2023). Top caregiver concerns in Rett syndrome and related disorders: data from the US natural history study. Journal of Neurodevelopmental Disorders. 15(1). 33–33. 36 indexed citations
6.
Olson, Heather E., Lindsay C. Swanson, Scott Demarest, et al.. (2021). Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder. Journal of Neurodevelopmental Disorders. 13(1). 40–40. 32 indexed citations
7.
Peters, Sarika U., Cary Fu, Jeffrey L. Neul, & Douglas A. Granger. (2020). Cortisol profiles and clinical severity in MECP2 duplication syndrome. Journal of Neurodevelopmental Disorders. 12(1). 19–19. 2 indexed citations
8.
Peters, Sarika U., Cary Fu, Eric D. Marsh, et al.. (2020). Phenotypic features in MECP2 duplication syndrome: Effects of age. American Journal of Medical Genetics Part A. 185(2). 362–369. 15 indexed citations
9.
Saby, Joni N., Jane B. Lane, Cary Fu, et al.. (2020). Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study. Annals of Neurology. 88(2). 396–406. 32 indexed citations
10.
Fu, Cary, Eric D. Marsh, David N. Lieberman, et al.. (2020). Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatrics Open. 4(1). e000717–e000717. 69 indexed citations
11.
Fu, Cary, Eric D. Marsh, David N. Lieberman, et al.. (2020). Multisystem comorbidities in classic Rett syndrome: a scoping review. BMJ Paediatrics Open. 4(1). e000731–e000731. 52 indexed citations
12.
Peters, Sarika U., Cary Fu, Bernhard Suter, et al.. (2019). Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome. Clinical Genetics. 95(5). 575–581. 38 indexed citations
13.
Zhang, Bo, Michael Wong, Kevin C. Ess, et al.. (2019). Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex. Neurobiology of Disease. 129. 93–101. 8 indexed citations
14.
15.
Grier, Mark D., Kathryn L. West, Nathaniel D. Kelm, et al.. (2017). Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination. PLoS ONE. 12(11). e0188417–e0188417. 26 indexed citations
16.
Lagrange, Andre H., et al.. (2015). Generalized onset seizures with focal evolution (GOFE) — A unique seizure type in the setting of generalized epilepsy. Epilepsy & Behavior. 54. 20–29. 11 indexed citations
17.
Fu, Cary & Kevin C. Ess. (2013). Conditional and domain‐specific inactivation of the Tsc2 gene in neural progenitor cells. genesis. 51(4). 284–292. 21 indexed citations
18.
Carson, Robert P., Cary Fu, Peggy Winzenburger, & Kevin C. Ess. (2012). Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. Human Molecular Genetics. 22(1). 140–152. 55 indexed citations
19.
Fu, Cary, et al.. (2008). Rapid one-step recombinational cloning. Nucleic Acids Research. 36(9). e54–e54. 33 indexed citations
20.
Maier, Robert J., Cary Fu, Joanne V. Gilbert, et al.. (1996). Hydrogen uptake hydrogenase inHelicobacter pylori. FEMS Microbiology Letters. 141(1). 71–76. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Chang Breakdown of academic impact, for papers by Zhengyu Cao Breakdown of academic impact, for papers by Xiaolu Deng Breakdown of academic impact, for papers by Paul Yao Breakdown of academic impact, for papers by Xukun Liu Breakdown of academic impact, for papers by Wenchao Li Breakdown of academic impact, for papers by Tanja Matijević Glavan Breakdown of academic impact, for papers by Kejin Zhang Breakdown of academic impact, for papers by Liping Hou Breakdown of academic impact, for papers by Xiaofeng Zhao
Rankless by CCL
2026